Ann: Cleansing Notice and Appendix 3B, page-2

Nils Debus is Head Business Development Biosimilars at Boehringer Ingelheim GmbH. The Boehringer Ingelheim group of companies is one of the world's leading pharmaceutical companies. We have remained a family-owned, independent company for well over a century. As our ownership has remained unchanged, so have our guiding principles. For over 129 years, we have practiced excellence, innovation and value in the discovery of medicines and services, and have remained committed to operating as an ethical and sustainable company. We are constantly seeking new and better ways to treat diseases in people and animals.

Albert Wong Originally from Hong Kong, Mr Wong has lived in Australia for over 35 years and has been involved in the stockbroking and investment banking industry for over 25 years. He was admitted as a Member of the Australian Stock Exchange in 1988 and was the principal of Intersuisse Limited until 1995 when he established the Barton Capital group of companies, including eStar Online. Both companies were listed on the Australian Securities Exchange. Mr Wong was a Founding Director of Gujarat NRE Resources NL and Pluton Resources Limited. He was been the business partner of the former NSW Premier, The Hon. Neville Wran AC QC at Wran Partners from 2004-2011.